Skip to main content
. 2017 Jun 9;13(9):2004–2016. doi: 10.1080/21645515.2017.1333211

Figure 2.

Figure 2.

Dengue neutralizing antibody GMTs (95% CI) in participants aged <9 y by baseline dengue status, region and study. PD3, post-dose 3; sero1–4, serotype 1–4.